Epicardial cardioverter-defibrillators do not cause postoperative arrhythmias. The CABG Patch Trial Investigators. Coronary Artery Bypass Graft.
The CABG Patch Trial is a controlled, multicenter clinical trial that randomized high-risk patients undergoing coronary artery bypass grafting (CABG) to prophylactic implantation of an epicardial implantable cardioverter-defibrillator (ICD) or to no additional treatment, permitting a controlled evaluation of the effect of epicardial ICDs on the incidence of postoperative arrhythmias. We found no significant difference in the development of postoperative arrhythmias between patients who received epicardial ICDs and the control group treated with CABG alone.